{"id":7100,"date":"2020-12-01T15:34:22","date_gmt":"2020-12-01T07:34:22","guid":{"rendered":"https:\/\/uatcphi.imsinoexpo.cn\/?p=7100"},"modified":"2021-12-27T13:26:07","modified_gmt":"2021-12-27T05:26:07","slug":"pharma-sources-insight-october-2020-focuses-on-pharma-landscape-in-china","status":"publish","type":"post","link":"https:\/\/www.cphi-china.cn\/en\/pharma-sources-insight-october-2020-focuses-on-pharma-landscape-in-china\/","title":{"rendered":"Pharma Sources Insight October 2020 Focuses on Pharma Landscape in China"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"7100\" class=\"elementor elementor-7100\" data-elementor-post-type=\"post\">\n\t\t\t\t\t\t<section data-particle_enable=\"false\" data-particle-mobile-disabled=\"false\" class=\"elementor-section elementor-top-section elementor-element elementor-element-81ba309 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"81ba309\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-abf5d26\" data-id=\"abf5d26\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-f4698ee elementor-widget elementor-widget-text-editor\" data-id=\"f4698ee\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<p><em>01.12.2020 15:34<\/em><\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section data-particle_enable=\"false\" data-particle-mobile-disabled=\"false\" class=\"elementor-section elementor-top-section elementor-element elementor-element-78ac640 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"78ac640\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-d2184d3\" data-id=\"d2184d3\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-759a30c elementor-widget elementor-widget-text-editor\" data-id=\"759a30c\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<p>With over 4000 pharmaceutical companies, China is the second-largest pharmaceutical industry globally. A report by Deux Consulting shows that China is estimated to reach $161.8 billion by 2023 and take a 30% share of the global market. The October Pharma Sources Insight will provide insights into the Chinese pharmaceutical industry on the following aspects, which offers an industry landscape in China.<\/p><p><strong>\u00a0<\/strong><\/p><p><strong>Pharma Sources Insight October 2020 <\/strong><strong>focuses on the following topics:<\/strong><\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section data-particle_enable=\"false\" data-particle-mobile-disabled=\"false\" class=\"elementor-section elementor-top-section elementor-element elementor-element-45be085 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"45be085\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-66bdc7f\" data-id=\"66bdc7f\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-129f265 elementor-widget elementor-widget-image\" data-id=\"129f265\" data-element_type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/flbook.com.cn\/c\/73ABnLNFKK\">\n\t\t\t\t\t\t\t<img fetchpriority=\"high\" decoding=\"async\" width=\"219\" height=\"300\" src=\"https:\/\/www.cphi-china.cn\/wp-content\/uploads\/2021\/12\/1-219x300.jpeg\" class=\"attachment-medium size-medium wp-image-7102\" alt=\"\" srcset=\"https:\/\/www.cphi-china.cn\/wp-content\/uploads\/2021\/12\/1-219x300.jpeg 219w, https:\/\/www.cphi-china.cn\/wp-content\/uploads\/2021\/12\/1-748x1024.jpeg 748w, https:\/\/www.cphi-china.cn\/wp-content\/uploads\/2021\/12\/1-768x1051.jpeg 768w, https:\/\/www.cphi-china.cn\/wp-content\/uploads\/2021\/12\/1.jpeg 950w\" sizes=\"(max-width: 219px) 100vw, 219px\" \/>\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section data-particle_enable=\"false\" data-particle-mobile-disabled=\"false\" class=\"elementor-section elementor-top-section elementor-element elementor-element-f079f12 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"f079f12\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-e7a48f9\" data-id=\"e7a48f9\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-8e05c4a elementor-widget elementor-widget-text-editor\" data-id=\"8e05c4a\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<p><span style=\"text-decoration: underline;\"><strong>PHARMA IN CHINA<\/strong><\/span><\/p><p>&#8211; Trends in China\u2019s Pharmaceutical Industry in 2020<\/p><p>&#8211; Chinese APIs and Their Role in the World\u2019s Pharmaceutical Industry<\/p><p>&#8211; Chinese Pharma Firms Can Support Africa Reduce Import Bill<\/p><p>&#8211; Insights into the Oncology Landscape in China<\/p><p>&#8211; The Impact of the Human Genome Project on China Pharmaceutical Industry 20 Years Later<\/p><p>&#8211; A Comparison of Top Ten Best-Selling Oncology Drugs in China and the U.S. in 2019<\/p><p>&#8211; Which Will Go Further? Innovent or Junshi?<\/p><p>&#8211; Production Applications of Chinese New Drugs in 2020 H1: Five Class 1 New Chemical Drugs, Two Anti-PD-1 Monoclonal Antibodies and Two CAR T-Cell Products Applied for Production for the First Time<\/p><p><span style=\"text-decoration: underline;\"><strong>Brand Story<\/strong><\/span><\/p><p>&#8211; PIONEER SPEED &#8211; Charming Fully Support All the Pharmaceutical Companies to Fight Against COVID-19<\/p><p>&#8211; Hiray Pharmaceutical, Innovating for Life<\/p><p>&#8211; An Opportunity for Pharmaceuticals Logistics During the Special Period : Cold Chain Railway Transport<\/p><p><span style=\"text-decoration: underline;\"><strong>Industry Insight<\/strong><\/span><\/p><p>&#8220;A Smarter Pharma Industry: The Key to Addressing Challenges During the COVID-19 Pandemic&#8221;<\/p><p>\u00a0<\/p><p style=\"color: #000000; font-family: sans-serif; font-size: 16px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px; margin: 5px 0px 5px 0px;\">\u00a0<\/p><p style=\"color: #000000; font-family: sans-serif; font-size: 16px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px; margin: 5px 0px 5px 0px;\">Click on the <a title=\"Pharma Sources Insight October 2020 Provides Pharma Landscape in China\" href=\"https:\/\/flbook.mwkj.net\/c\/73ABnLNFKK\" target=\"_blank\" rel=\"noopener\">link<\/a> or Scan the QR code to read the\u00a0<strong>Pharma Sources Insight (October 2020)<\/strong>:<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section data-particle_enable=\"false\" data-particle-mobile-disabled=\"false\" class=\"elementor-section elementor-top-section elementor-element elementor-element-f8025e6 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"f8025e6\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-4274fd9\" data-id=\"4274fd9\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-92e79d4 elementor-widget elementor-widget-image\" data-id=\"92e79d4\" data-element_type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" width=\"150\" height=\"150\" src=\"https:\/\/www.cphi-china.cn\/wp-content\/uploads\/2021\/12\/2-1-150x150.png\" class=\"attachment-thumbnail size-thumbnail wp-image-7104\" alt=\"\" srcset=\"https:\/\/www.cphi-china.cn\/wp-content\/uploads\/2021\/12\/2-1-150x150.png 150w, https:\/\/www.cphi-china.cn\/wp-content\/uploads\/2021\/12\/2-1-300x300.png 300w, https:\/\/www.cphi-china.cn\/wp-content\/uploads\/2021\/12\/2-1.png 430w\" sizes=\"(max-width: 150px) 100vw, 150px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section data-particle_enable=\"false\" data-particle-mobile-disabled=\"false\" class=\"elementor-section elementor-top-section elementor-element elementor-element-ae60170 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"ae60170\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-42a9fc9\" data-id=\"42a9fc9\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-0bd410f elementor-widget elementor-widget-text-editor\" data-id=\"0bd410f\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<p><strong>About Pharma Sources Insight<\/strong><\/p><p>\u00a0<\/p><p>Pharma Sources Insight is a unique source of updated coverages on current events and deep insights into hot areas of the pharma industry, from China to the world. It follows up new developments with those among the leading drug-manufacturers in China which further affect the world.<\/p><p>Now, join PharmaSources.com to get access to news of the Chinese pharmaceutical enterprises and to witness industrial changes through the exclusive perspectives of our expert writers into crucial aspects of the pharmaceutical field, all under PharmaSources.com and CPhI China.<\/p><p><strong><br \/><br \/><\/strong><\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>With over 4000 pharmaceutical companies, China is the second-largest pharmaceutical industry globally. A report by Deux Consulting shows that China is estimated to reach $161.8 billion by 2023 and take a 30% share of the global market. The October Pharma Sources Insight will provide insights into the Chinese pharmaceutical industry on the following aspects, which offers an industry landscape in China.<\/p>\n","protected":false},"author":8,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[217],"tags":[],"class_list":["post-7100","post","type-post","status-publish","format-standard","hentry","category-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>\u4e16\u754c\u5236\u836f\u539f\u6599\u5c55 - Pharma Sources Insight October 2020 Focuses on Pharma Landscape in China - CPHI China\u4e16\u754c\u5236\u836f\u539f\u6599\u4e2d\u56fd\u5c55<\/title>\n<meta name=\"description\" content=\"\u4e16\u754c\u5236\u836f\u539f\u6599\u4e2d\u56fd\u5c55\u7f51\u7f57\u5236\u836f\u539f\u6599\u3001\u533b\u836f\u4e2d\u95f4\u4f53\u3001\u751f\u7269\u6280\u672f\u3001\u533b\u836f\u5316\u5de5\u7b49\u5236\u836f\u5168\u4ea7\u4e1a\u94fe\u30022023\u533b\u836f\u5c55\u4f1a\u89c4\u6a21\u5c06\u8fbe20\u4e07\u5e73\u65b9\u7c73\uff0c\u96c6\u7ed320\u591a\u4e2a\u56fd\u5bb6\u548c\u5730\u533a\u76843,000\u4f59\u5bb6\u4f01\u4e1a\uff0c\u4ee5\u66f4\u5927\u89c4\u6a21\u3001\u66f4\u591a\u5c55\u5546\u3001\u66f4\u5168\u9762\u7684\u5c55\u793a\u8303\u56f4\u5438\u5f15\u8fd155,000+\u4eba\u6b21\u6d77\u5185\u5916\u89c2\u4f17\u3002\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cphi-china.cn\/en\/pharma-sources-insight-october-2020-focuses-on-pharma-landscape-in-china\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u4e16\u754c\u5236\u836f\u539f\u6599\u5c55 - Pharma Sources Insight October 2020 Focuses on Pharma Landscape in China - CPHI China\u4e16\u754c\u5236\u836f\u539f\u6599\u4e2d\u56fd\u5c55\" \/>\n<meta property=\"og:description\" content=\"\u4e16\u754c\u5236\u836f\u539f\u6599\u4e2d\u56fd\u5c55\u7f51\u7f57\u5236\u836f\u539f\u6599\u3001\u533b\u836f\u4e2d\u95f4\u4f53\u3001\u751f\u7269\u6280\u672f\u3001\u533b\u836f\u5316\u5de5\u7b49\u5236\u836f\u5168\u4ea7\u4e1a\u94fe\u30022023\u533b\u836f\u5c55\u4f1a\u89c4\u6a21\u5c06\u8fbe20\u4e07\u5e73\u65b9\u7c73\uff0c\u96c6\u7ed320\u591a\u4e2a\u56fd\u5bb6\u548c\u5730\u533a\u76843,000\u4f59\u5bb6\u4f01\u4e1a\uff0c\u4ee5\u66f4\u5927\u89c4\u6a21\u3001\u66f4\u591a\u5c55\u5546\u3001\u66f4\u5168\u9762\u7684\u5c55\u793a\u8303\u56f4\u5438\u5f15\u8fd155,000+\u4eba\u6b21\u6d77\u5185\u5916\u89c2\u4f17\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cphi-china.cn\/en\/pharma-sources-insight-october-2020-focuses-on-pharma-landscape-in-china\/\" \/>\n<meta property=\"og:site_name\" content=\"CPHI China\u4e16\u754c\u5236\u836f\u539f\u6599\u4e2d\u56fd\u5c55\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-01T07:34:22+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-12-27T05:26:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cphi-china.cn\/wp-content\/uploads\/2021\/12\/1-219x300.jpeg\" \/>\n<meta name=\"author\" content=\"StevenST.Sun@informa.com\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"StevenST.Sun@informa.com\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.cphi-china.cn\/en\/pharma-sources-insight-october-2020-focuses-on-pharma-landscape-in-china\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.cphi-china.cn\/en\/pharma-sources-insight-october-2020-focuses-on-pharma-landscape-in-china\/\"},\"author\":{\"name\":\"StevenST.Sun@informa.com\",\"@id\":\"https:\/\/www.cphi-china.cn\/en\/#\/schema\/person\/7e007d0a11d14b8f2b7117f2993b958f\"},\"headline\":\"Pharma Sources Insight October 2020 Focuses on Pharma Landscape in China\",\"datePublished\":\"2020-12-01T07:34:22+00:00\",\"dateModified\":\"2021-12-27T05:26:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.cphi-china.cn\/en\/pharma-sources-insight-october-2020-focuses-on-pharma-landscape-in-china\/\"},\"wordCount\":346,\"publisher\":{\"@id\":\"https:\/\/www.cphi-china.cn\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.cphi-china.cn\/en\/pharma-sources-insight-october-2020-focuses-on-pharma-landscape-in-china\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cphi-china.cn\/wp-content\/uploads\/2021\/12\/1-219x300.jpeg\",\"articleSection\":[\"NEWS\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cphi-china.cn\/en\/pharma-sources-insight-october-2020-focuses-on-pharma-landscape-in-china\/\",\"url\":\"https:\/\/www.cphi-china.cn\/en\/pharma-sources-insight-october-2020-focuses-on-pharma-landscape-in-china\/\",\"name\":\"\u4e16\u754c\u5236\u836f\u539f\u6599\u5c55 - Pharma Sources Insight October 2020 Focuses on Pharma Landscape in China - CPHI China\u4e16\u754c\u5236\u836f\u539f\u6599\u4e2d\u56fd\u5c55\",\"isPartOf\":{\"@id\":\"https:\/\/www.cphi-china.cn\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cphi-china.cn\/en\/pharma-sources-insight-october-2020-focuses-on-pharma-landscape-in-china\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cphi-china.cn\/en\/pharma-sources-insight-october-2020-focuses-on-pharma-landscape-in-china\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cphi-china.cn\/wp-content\/uploads\/2021\/12\/1-219x300.jpeg\",\"datePublished\":\"2020-12-01T07:34:22+00:00\",\"dateModified\":\"2021-12-27T05:26:07+00:00\",\"description\":\"\u4e16\u754c\u5236\u836f\u539f\u6599\u4e2d\u56fd\u5c55\u7f51\u7f57\u5236\u836f\u539f\u6599\u3001\u533b\u836f\u4e2d\u95f4\u4f53\u3001\u751f\u7269\u6280\u672f\u3001\u533b\u836f\u5316\u5de5\u7b49\u5236\u836f\u5168\u4ea7\u4e1a\u94fe\u30022023\u533b\u836f\u5c55\u4f1a\u89c4\u6a21\u5c06\u8fbe20\u4e07\u5e73\u65b9\u7c73\uff0c\u96c6\u7ed320\u591a\u4e2a\u56fd\u5bb6\u548c\u5730\u533a\u76843,000\u4f59\u5bb6\u4f01\u4e1a\uff0c\u4ee5\u66f4\u5927\u89c4\u6a21\u3001\u66f4\u591a\u5c55\u5546\u3001\u66f4\u5168\u9762\u7684\u5c55\u793a\u8303\u56f4\u5438\u5f15\u8fd155,000+\u4eba\u6b21\u6d77\u5185\u5916\u89c2\u4f17\u3002\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cphi-china.cn\/en\/pharma-sources-insight-october-2020-focuses-on-pharma-landscape-in-china\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cphi-china.cn\/en\/pharma-sources-insight-october-2020-focuses-on-pharma-landscape-in-china\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.cphi-china.cn\/en\/pharma-sources-insight-october-2020-focuses-on-pharma-landscape-in-china\/#primaryimage\",\"url\":\"https:\/\/www.cphi-china.cn\/wp-content\/uploads\/2021\/12\/1-219x300.jpeg\",\"contentUrl\":\"https:\/\/www.cphi-china.cn\/wp-content\/uploads\/2021\/12\/1-219x300.jpeg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cphi-china.cn\/en\/pharma-sources-insight-october-2020-focuses-on-pharma-landscape-in-china\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u9996\u9875\",\"item\":\"https:\/\/www.cphi-china.cn\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharma Sources Insight October 2020 Focuses on Pharma Landscape in China\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cphi-china.cn\/en\/#website\",\"url\":\"https:\/\/www.cphi-china.cn\/en\/\",\"name\":\"CPHI China\u4e16\u754c\u5236\u836f\u539f\u6599\u4e2d\u56fd\u5c55\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cphi-china.cn\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cphi-china.cn\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cphi-china.cn\/en\/#organization\",\"name\":\"CPHI China\u4e16\u754c\u5236\u836f\u539f\u6599\u4e2d\u56fd\u5c55\",\"url\":\"https:\/\/www.cphi-china.cn\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.cphi-china.cn\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cphi-china.cn\/wp-content\/uploads\/2021\/08\/CPHI_LOGO_RGB_CHINA_COLOUR_350_100.png\",\"contentUrl\":\"https:\/\/www.cphi-china.cn\/wp-content\/uploads\/2021\/08\/CPHI_LOGO_RGB_CHINA_COLOUR_350_100.png\",\"width\":350,\"height\":100,\"caption\":\"CPHI China\u4e16\u754c\u5236\u836f\u539f\u6599\u4e2d\u56fd\u5c55\"},\"image\":{\"@id\":\"https:\/\/www.cphi-china.cn\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cphi-china.cn\/en\/#\/schema\/person\/7e007d0a11d14b8f2b7117f2993b958f\",\"name\":\"StevenST.Sun@informa.com\",\"url\":\"https:\/\/www.cphi-china.cn\/en\/author\/stevenst-suninforma-com\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u4e16\u754c\u5236\u836f\u539f\u6599\u5c55 - Pharma Sources Insight October 2020 Focuses on Pharma Landscape in China - CPHI China\u4e16\u754c\u5236\u836f\u539f\u6599\u4e2d\u56fd\u5c55","description":"\u4e16\u754c\u5236\u836f\u539f\u6599\u4e2d\u56fd\u5c55\u7f51\u7f57\u5236\u836f\u539f\u6599\u3001\u533b\u836f\u4e2d\u95f4\u4f53\u3001\u751f\u7269\u6280\u672f\u3001\u533b\u836f\u5316\u5de5\u7b49\u5236\u836f\u5168\u4ea7\u4e1a\u94fe\u30022023\u533b\u836f\u5c55\u4f1a\u89c4\u6a21\u5c06\u8fbe20\u4e07\u5e73\u65b9\u7c73\uff0c\u96c6\u7ed320\u591a\u4e2a\u56fd\u5bb6\u548c\u5730\u533a\u76843,000\u4f59\u5bb6\u4f01\u4e1a\uff0c\u4ee5\u66f4\u5927\u89c4\u6a21\u3001\u66f4\u591a\u5c55\u5546\u3001\u66f4\u5168\u9762\u7684\u5c55\u793a\u8303\u56f4\u5438\u5f15\u8fd155,000+\u4eba\u6b21\u6d77\u5185\u5916\u89c2\u4f17\u3002","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cphi-china.cn\/en\/pharma-sources-insight-october-2020-focuses-on-pharma-landscape-in-china\/","og_locale":"en_US","og_type":"article","og_title":"\u4e16\u754c\u5236\u836f\u539f\u6599\u5c55 - Pharma Sources Insight October 2020 Focuses on Pharma Landscape in China - CPHI China\u4e16\u754c\u5236\u836f\u539f\u6599\u4e2d\u56fd\u5c55","og_description":"\u4e16\u754c\u5236\u836f\u539f\u6599\u4e2d\u56fd\u5c55\u7f51\u7f57\u5236\u836f\u539f\u6599\u3001\u533b\u836f\u4e2d\u95f4\u4f53\u3001\u751f\u7269\u6280\u672f\u3001\u533b\u836f\u5316\u5de5\u7b49\u5236\u836f\u5168\u4ea7\u4e1a\u94fe\u30022023\u533b\u836f\u5c55\u4f1a\u89c4\u6a21\u5c06\u8fbe20\u4e07\u5e73\u65b9\u7c73\uff0c\u96c6\u7ed320\u591a\u4e2a\u56fd\u5bb6\u548c\u5730\u533a\u76843,000\u4f59\u5bb6\u4f01\u4e1a\uff0c\u4ee5\u66f4\u5927\u89c4\u6a21\u3001\u66f4\u591a\u5c55\u5546\u3001\u66f4\u5168\u9762\u7684\u5c55\u793a\u8303\u56f4\u5438\u5f15\u8fd155,000+\u4eba\u6b21\u6d77\u5185\u5916\u89c2\u4f17\u3002","og_url":"https:\/\/www.cphi-china.cn\/en\/pharma-sources-insight-october-2020-focuses-on-pharma-landscape-in-china\/","og_site_name":"CPHI China\u4e16\u754c\u5236\u836f\u539f\u6599\u4e2d\u56fd\u5c55","article_published_time":"2020-12-01T07:34:22+00:00","article_modified_time":"2021-12-27T05:26:07+00:00","og_image":[{"url":"https:\/\/www.cphi-china.cn\/wp-content\/uploads\/2021\/12\/1-219x300.jpeg","type":"","width":"","height":""}],"author":"StevenST.Sun@informa.com","twitter_card":"summary_large_image","twitter_misc":{"Written by":"StevenST.Sun@informa.com","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.cphi-china.cn\/en\/pharma-sources-insight-october-2020-focuses-on-pharma-landscape-in-china\/#article","isPartOf":{"@id":"https:\/\/www.cphi-china.cn\/en\/pharma-sources-insight-october-2020-focuses-on-pharma-landscape-in-china\/"},"author":{"name":"StevenST.Sun@informa.com","@id":"https:\/\/www.cphi-china.cn\/en\/#\/schema\/person\/7e007d0a11d14b8f2b7117f2993b958f"},"headline":"Pharma Sources Insight October 2020 Focuses on Pharma Landscape in China","datePublished":"2020-12-01T07:34:22+00:00","dateModified":"2021-12-27T05:26:07+00:00","mainEntityOfPage":{"@id":"https:\/\/www.cphi-china.cn\/en\/pharma-sources-insight-october-2020-focuses-on-pharma-landscape-in-china\/"},"wordCount":346,"publisher":{"@id":"https:\/\/www.cphi-china.cn\/en\/#organization"},"image":{"@id":"https:\/\/www.cphi-china.cn\/en\/pharma-sources-insight-october-2020-focuses-on-pharma-landscape-in-china\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cphi-china.cn\/wp-content\/uploads\/2021\/12\/1-219x300.jpeg","articleSection":["NEWS"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.cphi-china.cn\/en\/pharma-sources-insight-october-2020-focuses-on-pharma-landscape-in-china\/","url":"https:\/\/www.cphi-china.cn\/en\/pharma-sources-insight-october-2020-focuses-on-pharma-landscape-in-china\/","name":"\u4e16\u754c\u5236\u836f\u539f\u6599\u5c55 - Pharma Sources Insight October 2020 Focuses on Pharma Landscape in China - CPHI China\u4e16\u754c\u5236\u836f\u539f\u6599\u4e2d\u56fd\u5c55","isPartOf":{"@id":"https:\/\/www.cphi-china.cn\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cphi-china.cn\/en\/pharma-sources-insight-october-2020-focuses-on-pharma-landscape-in-china\/#primaryimage"},"image":{"@id":"https:\/\/www.cphi-china.cn\/en\/pharma-sources-insight-october-2020-focuses-on-pharma-landscape-in-china\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cphi-china.cn\/wp-content\/uploads\/2021\/12\/1-219x300.jpeg","datePublished":"2020-12-01T07:34:22+00:00","dateModified":"2021-12-27T05:26:07+00:00","description":"\u4e16\u754c\u5236\u836f\u539f\u6599\u4e2d\u56fd\u5c55\u7f51\u7f57\u5236\u836f\u539f\u6599\u3001\u533b\u836f\u4e2d\u95f4\u4f53\u3001\u751f\u7269\u6280\u672f\u3001\u533b\u836f\u5316\u5de5\u7b49\u5236\u836f\u5168\u4ea7\u4e1a\u94fe\u30022023\u533b\u836f\u5c55\u4f1a\u89c4\u6a21\u5c06\u8fbe20\u4e07\u5e73\u65b9\u7c73\uff0c\u96c6\u7ed320\u591a\u4e2a\u56fd\u5bb6\u548c\u5730\u533a\u76843,000\u4f59\u5bb6\u4f01\u4e1a\uff0c\u4ee5\u66f4\u5927\u89c4\u6a21\u3001\u66f4\u591a\u5c55\u5546\u3001\u66f4\u5168\u9762\u7684\u5c55\u793a\u8303\u56f4\u5438\u5f15\u8fd155,000+\u4eba\u6b21\u6d77\u5185\u5916\u89c2\u4f17\u3002","breadcrumb":{"@id":"https:\/\/www.cphi-china.cn\/en\/pharma-sources-insight-october-2020-focuses-on-pharma-landscape-in-china\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cphi-china.cn\/en\/pharma-sources-insight-october-2020-focuses-on-pharma-landscape-in-china\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.cphi-china.cn\/en\/pharma-sources-insight-october-2020-focuses-on-pharma-landscape-in-china\/#primaryimage","url":"https:\/\/www.cphi-china.cn\/wp-content\/uploads\/2021\/12\/1-219x300.jpeg","contentUrl":"https:\/\/www.cphi-china.cn\/wp-content\/uploads\/2021\/12\/1-219x300.jpeg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.cphi-china.cn\/en\/pharma-sources-insight-october-2020-focuses-on-pharma-landscape-in-china\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u9996\u9875","item":"https:\/\/www.cphi-china.cn\/en\/"},{"@type":"ListItem","position":2,"name":"Pharma Sources Insight October 2020 Focuses on Pharma Landscape in China"}]},{"@type":"WebSite","@id":"https:\/\/www.cphi-china.cn\/en\/#website","url":"https:\/\/www.cphi-china.cn\/en\/","name":"CPHI China\u4e16\u754c\u5236\u836f\u539f\u6599\u4e2d\u56fd\u5c55","description":"","publisher":{"@id":"https:\/\/www.cphi-china.cn\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cphi-china.cn\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.cphi-china.cn\/en\/#organization","name":"CPHI China\u4e16\u754c\u5236\u836f\u539f\u6599\u4e2d\u56fd\u5c55","url":"https:\/\/www.cphi-china.cn\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.cphi-china.cn\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.cphi-china.cn\/wp-content\/uploads\/2021\/08\/CPHI_LOGO_RGB_CHINA_COLOUR_350_100.png","contentUrl":"https:\/\/www.cphi-china.cn\/wp-content\/uploads\/2021\/08\/CPHI_LOGO_RGB_CHINA_COLOUR_350_100.png","width":350,"height":100,"caption":"CPHI China\u4e16\u754c\u5236\u836f\u539f\u6599\u4e2d\u56fd\u5c55"},"image":{"@id":"https:\/\/www.cphi-china.cn\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.cphi-china.cn\/en\/#\/schema\/person\/7e007d0a11d14b8f2b7117f2993b958f","name":"StevenST.Sun@informa.com","url":"https:\/\/www.cphi-china.cn\/en\/author\/stevenst-suninforma-com\/"}]}},"_links":{"self":[{"href":"https:\/\/www.cphi-china.cn\/en\/wp-json\/wp\/v2\/posts\/7100","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cphi-china.cn\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cphi-china.cn\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cphi-china.cn\/en\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cphi-china.cn\/en\/wp-json\/wp\/v2\/comments?post=7100"}],"version-history":[{"count":5,"href":"https:\/\/www.cphi-china.cn\/en\/wp-json\/wp\/v2\/posts\/7100\/revisions"}],"predecessor-version":[{"id":21888,"href":"https:\/\/www.cphi-china.cn\/en\/wp-json\/wp\/v2\/posts\/7100\/revisions\/21888"}],"wp:attachment":[{"href":"https:\/\/www.cphi-china.cn\/en\/wp-json\/wp\/v2\/media?parent=7100"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cphi-china.cn\/en\/wp-json\/wp\/v2\/categories?post=7100"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cphi-china.cn\/en\/wp-json\/wp\/v2\/tags?post=7100"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}